Literature DB >> 21413001

How are symptoms of ovarian cancer managed? A study of primary care physicians.

Barbara A Goff1, Barbara Matthews, C Holly A Andrilla, Jacqueline W Miller, Katrina F Trivers, Donna Berry, Denise M Lishner, Laura-Mae Baldwin.   

Abstract

BACKGROUND: A study was undertaken to identify the diagnostic approaches that primary care physicians and gynecologists undertake in women with symptoms associated with ovarian cancer.
METHODS: A vignette-based survey was mailed to 3200 primary care physicians from the American Medical Association Physician Masterfile. The vignette described a 55-year-old woman with symptoms associated with ovarian cancer, although ovarian cancer was never mentioned. The authors evaluated patient, physician, and practice characteristics associated with a workup that could detect ovarian cancer.
RESULTS: The survey response rate was 61.7%. After exclusions, 1532 physicians were included. Overall, 89.5% of physicians reported that they would recommend testing that can detect ovarian cancer (71.2% ultrasound; 25.4% pelvic computed tomography; 26.5% CA125). In adjusted analysis, the only patient factor associated with ovarian cancer testing was symptom type, genitourinary versus gastrointestinal (risk ratio, 1.07; 95% confidence interval, 1.03-1.11). Physician and practice characteristics associated with recommending of ovarian cancer testing included specialty (gynecologists > family physicians and internists); type of practice (group > solo); clinical teaching (yes > no); and within Census division, location of practice, with all Central (East, West, North, and South) and Atlantic (Middle and South) areas having a lower likelihood than New England.
CONCLUSIONS: On the basis of a vignette in which a woman reported symptoms associated with ovarian cancer, the majority of primary care physicians and gynecologists would not recommend CA125, but would recommend imaging of the pelvis. Gynecologists, physicians involved with clinical teaching, and those in group practices were significantly more likely to recommend testing that could lead to an ovarian cancer diagnosis.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Year:  2011        PMID: 21413001     DOI: 10.1002/cncr.26035

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Symptom interpretation and health care seeking in ovarian cancer.

Authors:  Lene Seibaek; Lone K Petersen; Jan Blaakaer; Lise Hounsgaard
Journal:  BMC Womens Health       Date:  2011-06-23       Impact factor: 2.809

2.  Physicians' beliefs about effectiveness of cancer screening tests: a national survey of family physicians, general internists, and obstetrician-gynecologists.

Authors:  Jacqueline W Miller; Laura-Mae Baldwin; Barbara Matthews; Katrina F Trivers; C Holly Andrilla; Denise Lishner; Barbara A Goff
Journal:  Prev Med       Date:  2014-07-17       Impact factor: 4.018

3.  Guideline-inconsistent breast cancer screening for women over 50: a vignette-based survey.

Authors:  Hajar Kadivar; Barbara A Goff; William R Phillips; C Holly A Andrilla; Alfred O Berg; Laura-Mae Baldwin
Journal:  J Gen Intern Med       Date:  2013-08-14       Impact factor: 5.128

Review 4.  Platinum resistance in breast and ovarian cancer cell lines.

Authors:  Niels Eckstein
Journal:  J Exp Clin Cancer Res       Date:  2011-10-04

5.  Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.

Authors:  Janusz Menkiszak; Anita Chudecka-Głaz; Jacek Gronwald; Aneta Cymbaluk-Płoska; Aleksander Celewicz; Maria Świniarska; Małgorzata Wężowska; Ryszard Bedner; Dorota Zielińska; Paulina Tarnowska; Jerzy Jakubowicz; Zbigniew Kojs
Journal:  J Ovarian Res       Date:  2016-02-29       Impact factor: 4.234

6.  Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy.

Authors:  Janusz Menkiszak; Anita Chudecka-Głaz; Aneta Cymbaluk-Płoska; Aleksander Celewicz; Zbigniew Kojs; Mariusz Szajda; Maria Świniarska; Ryszard Bedner; Anna Jurczak; Marta Celewicz; Monika Cieszyńska; Jan Lubiński; Jacek Gronwald
Journal:  Hered Cancer Clin Pract       Date:  2019-03-14       Impact factor: 2.857

7.  Role of primary care physician factors on diagnostic testing and referral decisions for symptoms of possible cancer: a systematic review.

Authors:  Victoria Hardy; Adelaide Yue; Stephanie Archer; Samuel William David Merriel; Matthew Thompson; Jon Emery; Juliet Usher-Smith; Fiona M Walter
Journal:  BMJ Open       Date:  2022-01-24       Impact factor: 2.692

8.  Molecular subtypes, clinical significance, and tumor immune landscape of angiogenesis-related genes in ovarian cancer.

Authors:  Haixia Tang; Jingsong Shan; Juan Liu; Xuehai Wang; Fengxu Wang; Suping Han; Xinyuan Zhao; Jinxiu Wang
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

9.  Assessing Complex Emergency Management with Clinical Case-Vignettes: A Validation Study.

Authors:  Anne Rousseau; Patrick Rozenberg; Philippe Ravaud
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.